Clinical Trial Update: Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation

View source ↗

Summary

The study evaluating the status of subjects who discontinued participation in Amgen's AMG 073 trial due to kidney transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• AMG 073

Snippet

Sponsor: Amgen | Conditions: Kidney Transplantation | Status: COMPLETED